Month: October 2023

Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging the optic nerve. It is one of the leading

Lefamulin (Xenleta) is a new antibiotic that was approved by the FDA in 2019 for the treatment of community-acquired bacterial pneumonia (CABP). It belongs to

Hepatitis C is a chronic infection of the liver caused by a virus that can lead to serious complications such as cirrhosis, liver failure and

Leflunomide is a drug that belongs to the class of disease-modifying anti-rheumatic drugs (DMARDs). It is used to treat rheumatoid arthritis, a chronic inflammatory disease

Lenvatinib (brand name: Lenvima) is an oral targeted treatment that was developed by Eisai Co. and approved by the US Food and Drug Administration (FDA)

Lenalidomide, also known as Revlimid, is a prescription medicine that belongs to a class of drugs called immunomodulatory agents. It is used to treat various

Gout is a type of inflammatory arthritis that occurs when uric acid crystals build up in the joints, causing pain, swelling, and stiffness. Uric acid

Letermovir (Prevymis) is a new antiviral medicine that can prevent cytomegalovirus (CMV) infection and disease in adults who have received an allogeneic hematopoietic stem cell

Letrozole, also known by its brand name Femara, is a medication that lowers the production of estrogen in the body. It is used to treat

a Levalbuterol (Xopenex HFA) is a medication that belongs to the class of short-acting beta-agonists (SABA). It is used to treat or prevent sudden wheezing